Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2005
10/12/2005CN1679873A Sarcadra injection, its making method and venous injection
10/12/2005CN1679854A Medicine for preventing skin tumor tinea
10/12/2005CN1679842A Oldenlandia and powder injection and preparation thereof
10/12/2005CN1679841A Powder injection of sarcandra and its making method
10/12/2005CN1679827A Method for making substrate for paste from Chinese prickly ash and oral medicinal materials
10/12/2005CN1679798A Biological medicine with metabolic treatment and production thereof
10/12/2005CN1679797A Anti-cancer Tengli root extract and its making method and use
10/12/2005CN1679796A Anti-cancer compound preparation of giant knotweed, Tengli root and thinleaf adina root and its making method and use
10/12/2005CN1679795A Anti-cancer extracts from thinleaf adina root and its making method and use
10/12/2005CN1679793A Xiaoaiping preparation against cancers and its making method
10/12/2005CN1679775A Ointment of Bishutong for nasal obstruction
10/12/2005CN1679769A Chinese medicine composition for treating cancer
10/12/2005CN1679766A Shengmai injection use of medicine preparation for treating tumor attenuation
10/12/2005CN1679758A Zedoary oil injecting emulsion and preparation thereof
10/12/2005CN1679724A Chinese medicine preparation for treating tumor
10/12/2005CN1679712A Non-injection aromatic turmeric oil preparation and preparing method thereof
10/12/2005CN1679678A Aidi drops for treating cancers and preparation thereof
10/12/2005CN1679667A Guiyuan oral liquid and its preparing process
10/12/2005CN1679660A Pure natural antineoplastic medicine and preparation thereof
10/12/2005CN1679641A Use of tumor treating of recombinant adenoviral P53 products
10/12/2005CN1679637A Biological medicine for treating diseases from infection viral and bacterial
10/12/2005CN1679635A Antitumour Chinese medicine preparation
10/12/2005CN1679631A Compositions and uses of et743 for treating cancer
10/12/2005CN1679625A Medical use of engrafted nanometer carbon
10/12/2005CN1679604A Synergic medicine composition for resisting tumor
10/12/2005CN1679599A Double-layer delayed-releasing tablet of seudo-ginseng general saponin and production thereof
10/12/2005CN1679594A Anticarcinogenic compound medicinal preparation
10/12/2005CN1679590A Ethinyl estradiol gas permeable absorbing gel
10/12/2005CN1679589A Ethinyl estradiol gas permeable absorbing paste
10/12/2005CN1679587A Medicinal use of bromodihydroarteannuin
10/12/2005CN1679578A Fluorouracil injecting emulsion and production thereof
10/12/2005CN1679576A Stabilized oil-in-water emulsion of vinca alkaloids for vein and production thereof
10/12/2005CN1679575A 10-hydroxy camptothecine long circulating vesica and its freeze-dried preparation
10/12/2005CN1679574A Use of sinomenine
10/12/2005CN1679564A Method of treating of demyelinating diseases or conditions
10/12/2005CN1679562A Antiviral compounds
10/12/2005CN1679560A Stabilized oil-in-water emulsion of matrine alkaloid for venous purpose and production thereof
10/12/2005CN1679559A Cancer treatment
10/12/2005CN1679552A Preferential inhibition of release of pro-inflammatory cytokines
10/12/2005CN1679545A Andrographolide dispersing tablets
10/12/2005CN1679544A Use of dipolymer of phthalide
10/12/2005CN1679543A Medicine containing active components of methylcantharidimide and its preparing method and use
10/12/2005CN1679539A Synergic medicinal composition for preventing from tumor
10/12/2005CN1679538A Oral preparation of diterpene compounds against cancers and preparing method and use thereof
10/12/2005CN1679521A Use of substituting nitrobenzene derivative in products preparation
10/12/2005CN1679518A Magnetic medicinal capsules and preparation thereof
10/12/2005CN1222540C Monoclonal antibodies anti-CD6 and their uses
10/12/2005CN1222538C Active substance and composition inhibiting tumorous proliferation in ectoderm derived tissues
10/12/2005CN1222536C Prevention and treatment of hepatocellular cancer
10/12/2005CN1222529C Water soluble rapamycin esters
10/12/2005CN1222527C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
10/12/2005CN1222526C Chlorophyll and bacteriochlorophyll esters, and their preparation
10/12/2005CN1222523C 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors
10/12/2005CN1222520C Inhibitors of c-JUN N-terminal kinase (JNK) and other protein kinases
10/12/2005CN1222519C Reverse hydroxamate inhibitors of matrix metalloproteinases
10/12/2005CN1222510C Novel benzoylguanidine salt
10/12/2005CN1222374C Extrusion die
10/12/2005CN1222321C Pharmaceutical compositions containing cyclodextrins and taxoids
10/12/2005CN1222308C Chinese medicine for treating carcinoma of stomach
10/12/2005CN1222294C Combined preparations comprising morpholine anthracyclines and anticancer agent
10/12/2005CN1222292C Fulvestrant formulation
10/12/2005CN1222288C Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators
10/12/2005CN1222286C Methods of use for peroxynitrite decompositionc atalysts, pharmaceutical compositions therefor
10/12/2005CN1222285C Rebescensine A emulsion and its preparing method
10/11/2005US6953810 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
10/11/2005US6953806 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/11/2005US6953804 alkenyl ether functionality at 1-position; immunomodulators that induce cytokine biosynthesis; 1-[2-(2-Propynyloxy)ethyl]-1H-imidazo[4,5-c]quinolin-4-amine;
10/11/2005US6953797 Nitric oxide synthase inhibitor; antiinflammatory agents
10/11/2005US6953796 Use of 2-amino-thiazoline derivatives as inhibitors of inducible No-synthase
10/11/2005US6953795 N-[5-[[3[-(morpholin-4-yl)carbonyl]phenyl]thio]thiazol-2-yl]-4-(N,N-dimethylamino)benzamide; may be combined with antiinflammatory, antiarthritic, antiproliferative, anticancer, anti-cytotoxic or antiallergenic agents
10/11/2005US6953785 Estra-1,3,5(10)-triene derivatives
10/11/2005US6953778 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
10/11/2005US6953681 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
10/11/2005US6953670 Methods for identifying compounds capable of supplementing the biological activity of leptin
10/11/2005US6953579 Chimeric virus-like particle or chimeric capsomers from BPV
10/11/2005US6953570 For therapy of tumors
10/11/2005CA2373794C Compositions and uses of et743 for treating cancer
10/06/2005WO2005093090A1 Antisense oligonucleotides and uses thereof in improving cancer treatment strategies
10/06/2005WO2005093082A1 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelerator and apoptosis inhibitor
10/06/2005WO2005093067A1 Decoy nucleic acid to synoviolin gene promoter
10/06/2005WO2005093064A1 Novel galectin 9 modification protein and use thereof
10/06/2005WO2005093063A1 Kit for solid cancer diagnosis and medicine for solid cancer therapy
10/06/2005WO2005093048A1 Cancerous disease modifying antibodies
10/06/2005WO2005092916A1 Novel fermentation products
10/06/2005WO2005092904A1 Novel compounds for modulating cell proliferation
10/06/2005WO2005092902A1 Process for producing folic acid derivative
10/06/2005WO2005092898A1 The conjugates of a hydrophilic polymer-tripterygium's extracts and the pharmaceutical compositions thereof
10/06/2005WO2005092893A1 9-substituted 8-oxoadenine compound
10/06/2005WO2005092892A1 8-oxoadenine compound
10/06/2005WO2005092394A1 siRNA CAPABLE OF INHIBITING EXPRESSION OF WT1 GENE AND USE THEREOF
10/06/2005WO2005092393A1 Micro rna inhibiting the expression of wt1 gene and utilization of the same
10/06/2005WO2005092392A2 Conjugated psychotropic drugs and uses thereof
10/06/2005WO2005092389A1 Composite particle and coated composite particle
10/06/2005WO2005092388A1 Liposome preparation
10/06/2005WO2005092377A1 Cytotoxicity mediation of cells evidencing surface expression of cd63
10/06/2005WO2005092376A1 Cytotoxicity mediation of cells evidencing surface expression of mcsp
10/06/2005WO2005092375A1 Cytotoxicity mediation of cells evidencing surface expression of cd44
10/06/2005WO2005092351A1 The medical use of graft nano-carbon
10/06/2005WO2005092348A1 Hgf production accelerator containing heparin-like oligosaccharide
10/06/2005WO2005092322A1 Natural compound causing rar activation
1 ... 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 ... 2211